The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association between circulating tumor DNA and local tumor regrowth and distant metastasis during nonoperative management in stage I–III rectal cancer.
 
Kentaro Ochiai
No Relationships to Disclose
 
Megan Delisle
No Relationships to Disclose
 
Alisha Bent
No Relationships to Disclose
 
Van Morris
Consulting or Advisory Role - Abbvie; BioNTech SE; Bristol-Myers Squibb/Celgene; Exelixis; GlaxoSmithKline; Incyte; Pfizer
Research Funding - Bicara Therapeutics (Inst); BioNTech (Inst); Bristol-Myers Squibb (Inst); Pfizer (Inst)
 
Arvind Dasari
Consulting or Advisory Role - HutcMed; Illumina/GRAIL; Personalis; SIRTIS; Takeda
Research Funding - Eisai (Inst); Guardant Health (Inst); Hutchison MediPharma (Inst); Merck (Inst); Natera (Inst); XENCOR (Inst)
Travel, Accommodations, Expenses - Hutchison MediPharma; Takeda
 
Emma Holliday
No Relationships to Disclose
 
Timothy Newhook
No Relationships to Disclose
 
Kristin Alfaro
No Relationships to Disclose
 
Kathryn Aziz
Employment - MD Anderson Cancer Center
 
Paula Marincola Smith
No Relationships to Disclose
 
Ramy Behman
No Relationships to Disclose
 
Jeongyoon Moon
No Relationships to Disclose
 
Michael White
Consulting or Advisory Role - Sentinel Biotherapeutics
 
Craig Messick
No Relationships to Disclose
 
Y. Nancy You
No Relationships to Disclose
 
Brian Bednarski
No Relationships to Disclose
 
George Chang
Consulting or Advisory Role - Medicaroid
 
Jesse Joshua Smith
Consulting or Advisory Role - BioNTech SE; Foundation Medicine; Gerson Lehrman Group; GlaxoSmithKline; Guardant Health; Regeneron; Urogen pharma
Travel, Accommodations, Expenses - GlaxoSmithKline
Other Relationship - Johnson & Johnson/Janssen
 
Scott Kopetz
Stock and Other Ownership Interests - Frontier Medicines; Lutris; Navire
Consulting or Advisory Role - Alentis Therapeutics; AmMax Bio; Arcus Biosciences; AstraZeneca; AVEO; BeiGene; BioNTech SE; Boehringer Ingelheim; Bristol-Myers Squibb/Medarex; Carina Biotech; Clasp Therapeutics; Cytovation; Dewpoint Therapeutics; EMD Serono; Erasca, Inc; Flame Biosciences; Frontier Medicines; Genentech; Harbinger Oncology, Inc; Ikena Oncology; Iterion Therapeutics; Kivu Biosciences; Marengo Therapeutics; Pfizer; Regeneron; Roche; SageMedic; SERVIER; Shionogi; T-Cypher Bio; Tachyon Therapeutics; Transcode; XAIRA Therapeutics; Zentalis; Zentalis
Research Funding - Boehringer Ingelheim; EMD Serono; Genentech; Pfizer; Roche; Zentalis
 
Tsuyoshi Konishi
No Relationships to Disclose